USMLE Step 2 CK practice question: Giant cell arteritis with transient monocular vision loss: IV pulse glucocorticoids before biopsy
USMLE Step 2 CKMusculoskeletalInternal Medicine
Which of the following is the most appropriate next step in management?
- Temporal artery biopsy before glucocorticoid therapy
- Oral prednisone 15 mg daily
- Intravenous methylprednisolone
- Carotid duplex ultrasonography and aspirin
- Tocilizumab without glucocorticoids
Show answer and explanation
Correct answer: C. Intravenous methylprednisolone
This patient has giant cell arteritis (GCA): age >50 years, a new localized headache, scalp tenderness, jaw claudication, an abnormal temporal artery, constitutional symptoms, markedly elevated ESR and CRP, anemia of inflammation, and reactive thrombocytosis. GCA is a granulomatous vasculitis of large and medium-sized arteries, particularly the extracranial branches of the carotid artery. Her transient monocular vision loss (amaurosis fugax) reflects ischemia in the ophthalmic artery territory — most often the posterior ciliary arteries supplying the optic nerve head (the substrate of arteritic anterior ischemic optic neuropathy). It is a warning sign: permanent, often bilateral, blindness can follow within days and rarely recovers.
Glucocorticoids must be started immediately on clinical suspicion and should never be delayed for a biopsy. The 2021 ACR/Vasculitis Foundation guideline recommends high-dose oral glucocorticoids (e.g., prednisone 1 mg/kg/day, up to 60 mg) for GCA without cranial ischemic complications, but IV pulse methylprednisolone (typically 500–1000 mg daily for 3 days) for patients with threatened or active vision loss, followed by high-dose oral prednisone. Temporal artery biopsy (unilateral, a segment >1 cm long) is preferred for diagnosis in the United States and remains informative if performed within about 2 weeks of starting glucocorticoids, because granulomatous inflammation resolves slowly. Tocilizumab (an IL-6 receptor antagonist) added to tapering glucocorticoids is recommended for newly diagnosed GCA to reduce relapses and cumulative glucocorticoid exposure.
High-yield summary: Suspected GCA → glucocorticoids first, biopsy within 2 weeks. Visual symptoms (amaurosis fugax, diplopia, vision loss) → IV pulse methylprednisolone; otherwise oral prednisone 40–60 mg/day. Add tocilizumab as a glucocorticoid-sparing agent.
Why the other options are wrong
- A. Temporal artery biopsy before glucocorticoid therapy — Biopsy confirms the diagnosis but must not delay treatment; it remains informative for about 2 weeks after glucocorticoids are started, whereas untreated ocular ischemia can cause permanent blindness within hours to days.
- B. Oral prednisone 15 mg daily — Prednisone 12.5–25 mg daily is the starting dose for isolated polymyalgia rheumatica; it is inadequate for GCA, particularly with visual symptoms.
- D. Carotid duplex ultrasonography and aspirin — Amaurosis fugax in older adults can result from carotid atheroembolism, but jaw claudication, scalp tenderness, an abnormal temporal artery, and very high inflammatory markers point to GCA, which requires immediate glucocorticoids; aspirin alone does not treat vasculitis.
- E. Tocilizumab without glucocorticoids — Tocilizumab is used together with glucocorticoids as a glucocorticoid-sparing agent; its onset is too slow to protect vision, and it is not used as initial monotherapy.
Key point
In suspected giant cell arteritis with visual symptoms, start IV pulse methylprednisolone immediately — before temporal artery biopsy, which should be performed within 2 weeks.
Memory hook
GCA with any eye symptom: steroids before scalpel — pulse IV methylprednisolone now; the biopsy stays positive for about 2 weeks.
15 free bank questions a day, exam-length timed blocks, spaced repetition and 3D anatomy — in English and Russian.
Play free